Table 2.
Characteristics | Negative SARS-CoV-2 infectiona | Positive SARS-CoV-2 infectiona | P-value |
---|---|---|---|
n (%) | 569 | 103 | |
Age (years), mean (SD) | 64.4 (14.7) | 67.6 (15.4) | 0.05 |
Male (%) | 68.1 | 59.8 | 0.1 |
Dialysis vintage (months), median (IQR) | 31.1 (14.9–73.8) | 26.4 (11.8–62.2) | 0.1 |
Comorbidity | |||
Charlson comorbidity index, mean (SD) | 7.4 (3.1) | 8.1 (3.1) | 0.05 |
Overweightb (%) | 33.2 | 34.7 | 0.6 |
Obeseb (%) | 21.7 | 17.8 | 0.4 |
Hypertension (%) | 78.9 | 78.1 | 0.9 |
COPD (%) | 10.7 | 15.1 | 0.2 |
Diabetes mellitus (%) | 35.9 | 44.8 | 0.1 |
Smoker (%) | 16.5 | 20.2 | 0.4 |
Neoplasm (%) | 6.8 | 2.1 | 0.08 |
Risk factors for COVID-19 (%) | |||
Living with COVID-19 partner | 1.5 | 7.4 | <0.001 |
Living in nursing home | 1.6 | 9.9 | <0.001 |
Collective/public transport | 49.8 | 61.8 | 0.03 |
Previous hospital admission | 8.6 | 8.5 | 0.9 |
Treatment (%) | |||
ACEI | 15.9 | 21.1 | 0.2 |
ARB | 18.5 | 13.8 | 0.3 |
ACEI or ARB | 33.9 | 33.7 | 0.9 |
MRA | 2.8 | 3.2 | 0.8 |
IQR, interquartile range.
Negative SARS-CoV-2 infection includes patients with negative SARS-CoV-2 RT-PCR and anti-SARS-CoV-2 antibodies. Positive SARS-CoV-2 infection includes patients with positive SARS-CoV-2 RT-PCR and/or positive anti-SARS-CoV-2 antibodies. b Overweight: body mass index 25–30 kg/m2; obese: body mass index >30 kg/m2.